The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology (한방안이비인후피부과학회지)

The Society of Korean Medicine Ophthalmology, Otolaryngology & Dermatology (대한한방안이비인후피부과학회)
권호 표지
DOI QR코드

DOI QR Code

Systematic Review for the Development of the Clinical Study with Economical Assessment Protocol on Atopic Dermatitis

아토피 피부염의 임상연구병행 경제성평가 프로토콜 개발을 위한 체계적 문헌고찰연구

  • Gwon, Ji-Yae (School of Korean Medicine, Pusan National University) ;
  • Seon, Ji-Hye (Center for Comparative Effectiveness Research & Economic Evalution in Korean Medicine) ;
  • Yun, Hwa-Jeong (Department of Ophthalmology, Otorhinolaryngology & Dermatology of Korean Medicine Dong-Eui University Korean Medicine Hospital) ;
  • Kim, Nam-Kwen (Center for Comparative Effectiveness Research & Economic Evalution in Korean Medicine)
  • 권지예 (부산대학교 한의학전문대학원) ;
  • 선지혜 (부산대학교 한방 의료 비교효과 및 경제성평가 연구센터) ;
  • 윤화정 (동의대학교 한방병원 한방안이비인후피부과) ;
  • 김남권 (부산대학교 한의학전문대학원)
  • Received : 2017.01.17
  • Accepted : 2017.02.16
  • Published : 2017.02.25
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : The aim of this study is reviewing the literature to extracting the key parameter and finding the calibration parameter for the clinical study with economical assessment protocol on atopic dermatitis. Methods : Literature search is performed using PUBMED for literature published from Janurary 2000 to December 2016. We included randomized controlled trials(RCTs) with economic assessment in which human participants. Results : Among the articles published from January 2000 to December 2016, The 1464 articles were found. After reviewing the title, abstract and full text, the five articles were selected. Selected articles are classified 3 CEA(cost effective analysis)study, 1 CMA(cost minimizing analysis)study and 1 cost analysis study. Conclusions : We found highly reliable key parameters and calibration parameters, which might be necessary factors for developing research protocol of economic evaluation alongside clinical trial about atopic dermatitis patients.

Keywords

References

  1. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001;56(9):813-24. https://doi.org/10.1034/j.1398-9995.2001.t01-1-00001.x
  2. Park SE. A Study on the Etiology of Atopic Dermatitis. Journal of beauty industry. 2010;1(1):47-54.
  3. Gong NM, Jee SY. A Literature study about comparison of Eastern-Weatern medicine on the Atopic dermatitis. J Korean Med Ophtahlmol Otolaryngol Dermatol. 1999;12 (1):241-53.
  4. Peat JK, van der Berg RH, Green WF, Mellis CM, Leeder SR, Woolcock AJ. Changing prevalence of asthma in Australian children. BMJ. 1994;308:1591-6. https://doi.org/10.1136/bmj.308.6944.1591
  5. Aberg N, Hesselmar B, Aberg B, Eriksson B. Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clin Exp Allergy. 1995; 25:815-9. https://doi.org/10.1111/j.1365-2222.1995.tb00023.x
  6. Sugiura H, Umemoto N, Deguchi H. Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: Comparison with the disease frequency examined 20 years ago. Acta Derm Venereol(Stockh). 1998;78:293-4. https://doi.org/10.1080/000155598441891
  7. Han JY, Park HS. Prevalence of allergic diseases and its related factors in Korean adolescents-Using data from the 2013 Korea youth risk behavior web-based survey. Journal of the Korean Data & Information Science Society. 2016;27(1):155-68. https://doi.org/10.7465/jkdi.2016.27.1.155
  8. Chang DG, Choi HJ, Kim HS. Estimation of economic cost due to atopic dermatitis in Korea. Health Service Management Review. 2015;9(3):33-9. https://doi.org/10.18014/hsmr.2015.9.3.33
  9. Yun YH, Choi IH. Quality of life and economic impact of adult atopic dermatitis patient in seoul. J Korean Med Ophtahlmol Otolaryngol Dermatol. 2010;23(1):199-214.
  10. Kim SY, Park JE, Seo HJ, Seo HS, Son HJ, Shin CM, et al. NECA's guidance for undertaking systematic reviews and meta-analyses for intervention. National Evidence based Healthcare Collaborating Agency. 2011.
  11. Wollenberg A, Sidhu MK, Odeyemi I, Dorsch B, Koehne-Volland R, Schaff M, et al. Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis. The British journal of dermatology. 2008;159(6):1322-30. https://doi.org/10.1111/j.1365-2133.2008.08807.x
  12. Thaci D, Chambers C, Sidhu M, Dorsch B, Ehlken B, Fuchs S, et al. Twice-weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 months. Journal of the European Academy of Dermatology and Venereology. 2010;24(9): 1040-6. https://doi.org/10.1111/j.1468-3083.2010.03577.x
  13. Schuttelaar ML, Vermeulen KM, Coenraads PJ. Costs and cost-effectiveness analysis of treatment in children with eczema by nurse practitioner vs. dermatologist: results of a randomized, controlled trial and a review of international costs. The British journal of dermatology. 2011;165(3):600-11. https://doi.org/10.1111/j.1365-2133.2011.10470.x
  14. van Os-Medendorp H, Koffijberg H, Eland-de Kok PC, van der Zalm A, de Bruin-Weller MS, Pasmans SG, et al. E-health in caring for patients with atopic dermatitis: a randomized controlled cost-effectiveness study of internet-guided monitoring and online self-management training. The British journal of dermatology. 2012;166(5):1060-8. https://doi.org/10.1111/j.1365-2133.2012.10829.x
  15. Kiencke P, Viehmann K, Rychlik R. Cost-effectiveness analysis, prevention of atopic dermatitis by oral application of bacterial lysate in newborns/small children. The European journal of health economics: HEPAC. 2013;14(6):995-1002. https://doi.org/10.1007/s10198-012-0448-x
  16. Kang KH, Kim KW, Kim DH. Utilization Pattern and Cost of Medical Treatment and Complementary Alternative Therapy in Children with Atopic Dermatitis. Pediatric allergy and respiratory disease. 2012;22(1): 27-36. https://doi.org/10.7581/pard.2012.22.1.27
  17. Kim EJ, Kim HO, Park YM. A Study on Quality of Life and Economic Burden in Korean Patients with Atopic Dermatitis and Their Parents. Korean journal of dermatology. 2008;46(2):160-70.
  18. Kim DH, Lee KS, Seo SJ, Cho SJ, Lim HU, Kim CM, et al. Research of understanding and social loss of atopic dermatitis in Korea. 2011;49(20):145-45.
  19. Choi SY, Park KY, Li KS, Seo SJ, Kim GH, Kim DW, et al. Comparison Severity of Scoring Systems of Atopic Dermatitis. Journal of Korean Dermatology. 2013;51(4):243-480.
  20. Han DS, Hyun BR. Doctor-centered Telemedicine System. Korea Information Science Society. 2008;35(2):238-43.
  21. Garrison LP, Mansley EC, Abbott TA, Bresnahan BW, Hay JW, Smeeding J. Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report-Part II. Value in Health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2010;13(1):8-13. https://doi.org/10.1111/j.1524-4733.2009.00660.x